Acrivon Therapeutics (ACRV) Stock Chart & Stock Price History $1.52 -0.03 (-2.19%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acrivon Therapeutics Stock Price Performance The Acrivon Therapeutics (ACRV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 83.55%, with a year-to-date return of -74.75%. In the past month, the stock has increased 21.60%, reflecting recent market activity. As of the latest close, Acrivon Therapeutics traded at $1.55 with a market cap of $48.76 million and volume of 1.07 million shares. Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+14.29%1 Month Performance+21.60%3 Month Performance+19.69%Year-To-Date Performance-74.75%1 Year Performance-83.55% ACRV Stock Chart for Friday, September, 12, 2025 ACRV Chart by TradingView Acrivon Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/11/2025$1.63$1.55-4.91%$1.66$1.501.07 million shs$48.76 million09/10/2025$1.65$1.63-1.21%$1.72$1.60844,100 shs$51.28 million09/09/2025$1.79$1.65-7.82%$1.86$1.553.39 million shs$51.91 million09/08/2025$1.33$1.79+34.59%$2.67$1.3551.40 million shs$56.31 million09/05/2025$1.30$1.33+2.31%$1.37$1.303.44 million shs$41.84 million09/04/2025$1.34$1.30-2.99%$1.35$1.30216,544 shs$40.90 million09/03/2025$1.34$1.34$1.38$1.3397,765 shs$42.16 million09/02/2025$1.34$1.34$1.40$1.3178,189 shs$42.15 million09/01/2025$1.34$1.34$1.37$1.3266,454 shs$42.16 million08/29/2025$1.33$1.34+0.75%$1.37$1.3266,454 shs$42.16 million Get the Latest News and Ratings for ACRV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/28/2025$1.36$1.33-2.21%$1.40$1.33106,124 shs$41.84 million08/27/2025$1.33$1.36+2.26%$1.38$1.31186,985 shs$42.78 million08/26/2025$1.33$1.33$1.35$1.30147,948 shs$41.84 million08/25/2025$1.36$1.33-2.21%$1.39$1.33141,341 shs$41.84 million08/22/2025$1.32$1.36+3.03%$1.42$1.31226,904 shs$42.79 million08/21/2025$1.30$1.32+1.54%$1.34$1.27111,773 shs$41.53 million08/20/2025$1.30$1.30$1.35$1.29198,742 shs$40.89 million08/19/2025$1.39$1.30-6.47%$1.40$1.30429,270 shs$40.90 million08/18/2025$1.35$1.39+2.96%$1.44$1.38256,551 shs$43.73 million08/15/2025$1.39$1.35-2.88%$1.43$1.34213,026 shs$42.32 million08/14/2025$1.31$1.39+6.11%$1.39$1.26333,721 shs$43.58 million08/13/2025$1.25$1.31+4.80%$1.33$1.25224,350 shs$41.07 million08/12/2025$1.23$1.25+1.63%$1.28$1.21144,634 shs$39.19 million08/11/2025$1.24$1.23-0.81%$1.27$1.20134,330 shs$38.57 million Related Companies Nuvectis Pharma Stock Chart Seres Therapeutics Stock Chart Lifevantage Stock Chart Kyverna Therapeutics Stock Chart MEI Pharma Stock Chart Black Diamond Therapeutics Stock Chart Greenwich LifeSciences Stock Chart Milestone Pharmaceuticals Stock Chart Eledon Pharmaceuticals Stock Chart Molecular Partners Stock Chart Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRV) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acrivon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACRV Stock Alerts